Obstetrics & Gynecology Specialist | Gynecologic Oncology Surgeon Appointments in Türkiye via MHRS
HPV · Results

What do CIN 1, CIN 2 and CIN 3 mean?

Short answer

CIN is the name for changes in the cells of the cervix that are considered precancerous. It is not cancer itself. The grade rises from 1 to 3: CIN 1 is mild (it often goes away on its own and is frequently monitored), while CIN 2-3 is more advanced (usually treated). The decision is not based on a single result; your doctor makes it based on your age, your HPV type and your previous tests. When addressed in time, CIN is a stage that can be resolved before cancer develops.

Seeing "CIN 1", "CIN 2" or "CIN 3" on a pathology report can be worrying. This article aims to explain these terms in a calm and clear way. Let's start with the most important message: CIN is not cancer. It is a precancerous stage that can usually be managed.

What is CIN?

CIN (cervical intraepithelial neoplasia) is the name for changes in the cells of the cervix that are considered precancerous. It is usually linked to a persistent high-risk HPV infection and is most often found through a biopsy taken during a colposcopy.

The difference between CIN 1, 2 and 3

The number shows the depth/grade of the change:

GradeMeaningGeneral approach
CIN 1Mild changeOften monitored; usually goes away
CIN 2Moderate changeMonitoring or treatment, depending on age
CIN 3High-grade changeUsually treated

Is it cancer?

No. CIN is not cancer itself; it is a precancerous stage. CIN 1 in particular often goes away on its own. The risk rises with higher grades (CIN 2-3), but treatment largely prevents this progression. That is exactly why screening and follow-up are so valuable: they catch the change before it becomes cancer.

Which is monitored, which is treated?

Monitoring

CIN 1, and in some cases (especially in younger women) CIN 2, with careful follow-up.

Treatment

CIN 2-3 is usually treated; the most common method is LEEP.

The decision is not based on a single result. It is made by looking at your age, your HPV type and your previous tests together.

Afterward: follow-up

Whether monitoring or treatment is chosen, follow-up continues afterward, to catch any recurrence or new change early. Not missing your follow-up appointments is the most important part of the process.

When should you see a doctor?

  • If your report mentions CIN and you are not sure what it means,
  • If your recommended monitoring or treatment appointment is due,
  • If your post-treatment check-up is coming up.

In short, CIN is a stage that can be resolved with an early and appropriate step before it turns into cancer. For all the terms: HPV results glossary.

Frequently asked questions

Is CIN cancer?

No. CIN describes precancerous cell changes in the cervix; it is not cancer itself. When addressed in time, it is a stage that can be resolved before cancer develops.

Does CIN 1 need to be treated?

Most of the time, no. CIN 1 is a mild change that often goes away on its own; it is usually monitored. The treatment decision is up to your doctor.

My result shows CIN 2 or CIN 3. What happens now?

These are more advanced changes and are usually treated (for example, with LEEP). The aim is to prevent the change from progressing to cancer. Decisions take your age and your other results into account.

Will CIN definitely turn into cancer?

No. Low-grade changes in particular often go away. The risk rises with higher grades, but treatment largely prevents this progression. That is why follow-up matters.

How is CIN diagnosed?

It is usually diagnosed by pathology examination of a biopsy (tissue sample) taken during colposcopy. For details of the procedure, see our article on colposcopy.

Sources

  1. ASCCP — CIN management and treatment approaches.
  2. National Cancer Institute (NCI) — cervical intraepithelial neoplasia.
  3. ACOG — abnormal cervical screening results.

Note: This content was written independently, based on current scientific information published by the institutions above; it is not a direct copy of any text.

Assoc. Prof. Dr. Emre Mat
Assoc. Prof. Dr. Emre Mat
Obstetrics and Gynecology · Gynecologic Oncology

Obstetrics and Gynecology specialist and Gynecologic Oncology surgeon; Bakırçay University Çiğli Training and Research Hospital, İzmir. About · ORCID

Responsibility and scope

This article is for general information only; it is not a diagnosis or treatment recommendation and does not replace a medical examination. Please consult your doctor about your own situation. The content reflects scientific knowledge as of the update date above.